EEF1A1 and B-cell chronic lymphocytic leukemia: Recently, we have shown that the DNA aptamer GT75, which targets eEF1A1, can inhibit the viability of a panel of human HCCs [9] and the chronic lymphocytic leukaemia cells [34].